Purpose
PRE-PROPOSAL - to evaluate the relative efficacy of a trivalent P2-VP8 parenteral rotavirus vaccine compared to a licensed oral rotavirus vaccine to prevent severe rotavirus gastroenteritis in infants in lower-income settings
Grantee
Division
Date
MARCH 2019
Region served
ASIA
Committed amount
$300,000
Grant topic
Duration (months)
46
Grantee location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.